We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.6B
AUM Growth
-$97.4M
Cap. Flow
-$358M
Cap. Flow %
-22.36%
Top 10 Hldgs %
23.75%
Holding
355
New
77
Increased
81
Reduced
79
Closed
59

Top Buys

Rank Stock Value
1
SSE
SEVENTY SEVEN ENERGY INC COM
SSE
+$30.2M
2
GWRU
GENESEE & WYOMING INC TANGIBLE EQUITY UNIT (DE)
GWRU
+$8.7M
3
TSNU
Tyson Foods, Inc.
TSNU
+$7.62M
4
WEX icon
WEX
WEX
+$7.55M
5
LAZ icon
Lazard
LAZ
+$7.01M

Top Sells

Rank Stock Value
1
CHK
Chesapeake Energy Corporation
CHK
+$60.7M
2
AVNT icon
Avient
AVNT
+$10.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.3M
4
AGN
Allergan plc
AGN
+$9.19M
5
KATE
Kate Spade & Company
KATE
+$6.87M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.7%
2 Industrials 11.56%
3 Energy 9.87%
4 Technology 8.2%
5 Healthcare 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWONA icon
226
Liberty Media Series A
FWONA
$23.5B
$1.32M 0.08%
55,019
-100,042
-65% -$2.46M
BAC icon
227
Bank of America
BAC
$442B
$1.18M 0.07%
+69,358
New +$1.1M
JPM icon
228
JPMorgan Chase
JPM
$950B
$1.16M 0.07%
19,274
-7,382
-28% -$432K
ICPT
229
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.07M 0.07%
4,542
-3,384
-43% -$863K
NEO icon
230
NeoGenomics
NEO
$2.13B
$1.02M 0.06%
+195,573
New +$1M
STRR
231
DELISTED
Star Equity Holdings
STRR
$971K 0.06%
4,942
+461
+10% +$82.7K
LOXO
232
DELISTED
Loxo Oncology, Inc
LOXO
$963K 0.06%
+73,341
New +$952K
SBUX icon
233
Starbucks
SBUX
$120B
$785K 0.05%
20,808
-40,726
-66% -$1.58M
COST icon
234
Costco
COST
$420B
$772K 0.05%
+6,162
New +$745K
VIRX
235
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$751K 0.05%
501
-969
-66% -$1.4M
INNL
236
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$642K 0.04%
+97,344
New +$795K
ALDR
237
DELISTED
Alder Biopharmaceuticals
ALDR
$626K 0.04%
49,341
-1,115
-2% -$16.9K
ESPR
238
DELISTED
Esperion Therapeutics
ESPR
$589K 0.04%
+24,070
New +$383K
BABA icon
239
Alibaba
BABA
$308B
$388K 0.02%
+4,362
New +$392K
ORB
240
DELISTED
ORBITAL SCIENCES CORP
ORB
$381K 0.02%
+13,706
New +$377K
TXMD icon
241
TherapeuticsMD
TXMD
$24M
$348K 0.02%
1,498
-8,993
-86% -$2.27M
WINT
242
DELISTED
Windtree Therapeutics Inc
WINT
$189K 0.01%
+7,340
New +$177K
TRIB
243
Trinity Biotech
TRIB
$8.39M
$183K 0.01%
67
-395
-85% -$1.28M
ALSN icon
244
Allison Transmission
ALSN
$9.82B
– –
-188,771
Closed -$5.87M
AVNT icon
245
Avient
AVNT
$4.19B
– –
-248,268
Closed -$10.5M
AXON
246
Axon Enterprise
AXON
$46.4B
– –
-225,258
Closed -$3M
BF.B icon
247
Brown-Forman Class B
BF.B
$13.1B
– –
-199,941
Closed -$6.03M
CHRD icon
248
Chord Energy
CHRD
$7.39B
– –
-82,972
Closed -$4.64M
CMI icon
249
Cummins
CMI
$88.7B
– –
-9,703
Closed -$1.5M
CP icon
250
Canadian Pacific Kansas City
CP
$80.5B
– –
-49,850
Closed -$1.81M
8 9
10
11 12

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Nicholas Investment Partners held 355 positions worth $1.6B, down 5.7% from $1.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Nicholas Investment Partners withdrew a net $358M in Q3 2014, closing 59 positions and reducing 79 holdings. Its most notable exit was Avient, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 17% a quarter earlier, followed by Industrials and Energy.

Against the trend, Nicholas Investment Partners opened a new position in SEVENTY SEVEN ENERGY INC COM worth $30.1M.

  • Nicholas Investment Partners's largest Q3 2014 buy was SEVENTY SEVEN ENERGY INC COM: 1,265,892 shares worth $30.1M.
  • Nicholas Investment Partners added most to GENESEE & WYOMING INC TANGIBLE EQUITY UNIT (DE) in Q3 2014, an estimated $8.7M increase.
  • Nicholas Investment Partners's biggest Q3 2014 reduction was Chesapeake Energy Corporation, cutting an estimated $60.7M.
  • Nicholas Investment Partners fully exited Avient in Q3 2014, selling an estimated $10.5M.
  • Nicholas Investment Partners's ten largest holdings make up 24% of its $1.6B portfolio in Q3 2014.
  • Nicholas Investment Partners opened 77 new positions and closed 59 in Q3 2014.
  • Nicholas Investment Partners's portfolio value fell 5.7% quarter-over-quarter to $1.6B.

Based on Nicholas Investment Partners's 13F filing for Q3 2014, filed 5 Nov 2014.